Add BrightSurf on Google Email

New single-cell lineage tracing technique offers detailed insights into drivers of metastasis

A new method traces real-time cancer progression across thousands of cells, identifying rare events and distinct gene expression profiles associated with metastatic phenotypes. The approach could inform aspects of cellular cancer biology, including genetic mutations, microenvironment adaptation and resistance to therapeutic agents.

Spontaneous cell fusions amplify genetic diversity within tumors, Moffitt researchers say

Researchers at Moffitt Cancer Center discovered that cancer cells can fuse and recombine their genetic material, leading to increased diversity and adaptability. This mechanism, similar to parasexual recombination in pathogenic microbes, enables cancer cells to rapidly evolve and acquire resistance to treatments.

SourceH. Lee Moffitt Cancer Center & Research Institute·JournalNature Ecology & Evolution·DateJan 20, 2021

Nanodiamonds feel the heat

Researchers created nanodiamond sensors that can act as both heat sources and thermometers, allowing for the measurement of thermal conductivity inside living cells. This breakthrough may lead to new diagnostics tools and cancer therapies, as well as a better understanding of metabolic disorders such as obesity.

Moffitt researchers discover biochemical pathway that protects cells from ferroptosis

Researchers at Moffitt Cancer Center have identified a novel biochemical pathway that protects cells from ferroptosis, a type of cell death caused by oxidation imbalance. The discovery involves the activation of the protein GCLC, which leads to the production of gamma-glutamyl-peptides that shield cells against ferroptosis.

Ovarian cancer cells adapt to their surroundings to aid tumor growth

Researchers discovered that ovarian cancer cells undergo structural changes in their mitochondria to survive and proliferate in the peritoneal cavity. This adaptation enables aggressive cancerous cells to grow and spread, making it harder to detect and treat. Understanding these cellular adaptations could lead to new targeted therapies.

SourceFrontiers·JournalFrontiers in Oncology·DateJan 13, 2021

Acta Pharmaceutica Sinica Bvolume 10, issue 12 publishes

This issue of APSB features studies on the anticancer effects of berberine, baicalein's potent antivirus ability against HSV-1, and a new class of PDE10A inhibitors for treating PAH. Additionally, several articles explore innovative drug delivery systems and novel targets for cancer therapy.

SourceCompuscript Ltd·JournalActa Pharmaceutica Sinica B·DateJan 11, 2021

Understanding how to improve antibodies targeting OX40 for the treatment of cancer

Scientists at the University of Southampton have discovered that modifying antibodies to target OX40 can enhance immune responses against cancer cells. By adjusting the antibody's isotype, researchers found that one type can delete suppressive Treg cells and another can stimulate killer T-cells, leading to improved anti-tumor effects.

SourceUniversity of Southampton·JournalJournal for ImmunoTherapy of Cancer·DateJan 8, 2021

Do tumors stiff-arm the immune system?

Tumor cells produce excess complement protein iC3b to mask abnormal proteins, evading immune cell attack. The immune system relies on a flexible receptor CR3 to distinguish between 'I belong' and 'I don't belong' tags.

SourceInsideOutBio·JournalJournal for ImmunoTherapy of Cancer·DateDec 15, 2020

Signs of healthy aging found in ergothioneine telomere study

A recent in vitro study published in Journal of Dietary Supplements found that ergothioneine helped preserve telomere length and reduce oxidative stress. The study suggests that ergothioneine as part of a healthy diet could potentially mitigate the negative effects of oxidative stress and support healthy aging by preserving telomeres.

SourceBlue California·JournalJournal of Dietary Supplements·DateDec 10, 2020

AI predicts which drug combinations kill cancer cells

A machine learning model developed in Finland can identify best cancer drug combinations to selectively kill specific cancer cells with unique genetic or functional profiles. The AI model accurately predicts how different drug combinations inhibit particular cancer cells, paving the way for more effective cancer treatments.

SourceAalto University·JournalNature Communications·DateDec 1, 2020

Minuscule migrations

Researchers studied fruit fly ovaries to understand cellular motion, discovering that tissue geometry creates a path of least resistance. The team found that cells choose central paths despite multiple side paths available, and this choice is influenced by the physical space, not just chemical signals.

Drug discovery: First highly scalable method to monitor protein levels and localizations

Researchers at CeMM have developed a scalable method to study hundreds of proteins in parallel, enabling the observation of changes in protein levels and localization in real-time. This approach has potential applications in discovering new drug treatments and understanding proteome dynamics.

Cancer-fighting gene restrains 'jumping genes'

Scientists have discovered a new role for the cancer-fighting gene p53 in preventing retrotransposons from hopping around the human genome, potentially leading to new ways of detecting or treating cancers. The study found that cells without functional p53 had higher rates of retrotransposon movement and multiplication.

SourceUT Southwestern Medical Center·JournalGenes & Development·DateOct 29, 2020

Watch how cells squeeze through channels

Researchers observed cells moving through small channels to understand cell migration in 3D environments. The findings suggest that cancer cells may penetrate tissues and be blocked within small capillaries, potentially allowing them to metastasize.

SourceCell Press·JournalBiophysical Journal·DateOct 6, 2020